**Core Concept:** G-6-Phosphatase is a crucial enzyme involved in the **glycolysis** pathway, particularly in the **hepatic tissue**. It plays a significant role in regulating the conversion of glucose-6-phosphate to fructose-6-phosphate. **G-6-Phosphatase deficiency** leads to impaired glucose utilization and accumulation of glucose-6-phosphate, resulting in various clinical manifestations.

**Why the Correct Answer is Right:**

G-6-Phosphatase deficiency is primarily a **hereditary disorder** caused by mutations in the SLC39A14 gene, encoding for the ZIP14 transporter. This deficiency results in decreased glucose uptake and utilization by the liver, leading to glucose-6-phosphate accumulation. As glucose-6-phosphate is a key intermediate in glycolysis, this deficiency impairs glycolysis, ultimately causing hypoglycemia, hyperglycemic crisis, and a characteristic "salt-wasting" phenotype.

**Why Each Wrong Option is Incorrect:**

A. This option refers to **hypoglycemia** due to impaired glucose uptake, which is the opposite of the correct answer. G-6-Phosphatase deficiency results in hyperglycemia, not hypoglycemia.

B. This option refers to a condition characterized by **hyperglycemia and hyperinsulinemia** due to decreased glucose uptake, which is again the opposite of the correct answer. G-6-Phosphatase deficiency leads to hypoglycemia, not hyperglycemia.

C. This option refers to a condition characterized by **hypoglycemia and hyperinsulinemia**, which is the opposite of the correct answer. G-6-Phosphatase deficiency results in hyperglycemia, not hypoglycemia.

D. This option refers to a condition characterized by **hypoglycemia and hyperinsulinemia**, which is the opposite of the correct answer. G-6-Phosphatase deficiency leads to hyperglycemia, not hypoglycemia.

**Clinical Pearl:**

Understanding G-6-Phosphatase deficiency is essential for recognizing the clinical presentation of this disorder, which includes neonatal hypoglycemia, hyperinsulinemia, and characteristic "salt-wasting" phenotype due to impaired sodium reabsorption in the kidney. This information is crucial for diagnosing and managing patients with these clinical features.